LONDON, June 13, 2024 /PRNewswire/ — According to Omdia’s latest report, the global market for OLED materials is poised for a rebound after experiencing a deficit in recent years. The findings from Omdia’s latest ‘OLED Materials Market Tracker – 2Q24C‘ released in June, indicate a shift in trajectory. While OLED materials had been on a […]
Category Archives: Pr Newswire
Concordia Shanghai named in Top 10 shortlist for World’s Best School Prize for Supporting Healthy Lives SHANGHAI, June 13, 2024 /PRNewswire/ — An international school in China has been named in the Top 10 shortlists for the World’s Best School Prizes 2024. The five World’s Best School Prizes, founded by T4 Education in collaboration with […]
ARLINGTON, Va., June 13, 2024 /PRNewswire/ — Today, Venture Global and D. TRADING (commercial arm of DTEK Group) announced the execution of a comprehensive Heads of Agreement (HOA) for the supply of U.S. liquefied natural gas (LNG) to Ukraine and Eastern Europe. The HOA provides that DTEK’s subsidiary, D. TRADING, will purchase cargoes from Venture […]
GUELPH, ON, June 13, 2024 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) announced today that it has entered into an agreement with U.S. homebuilder D.R. Horton to offer its solar and energy storage products across communities in California. Under the agreement, Canadian Solar will provide a total home energy battery back-up […]
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 13, 2024 /PRNewswire/ — Sirnaomics Ltd. (the “Company”; together with its subsidiaries, “Sirnaomics” or the “Group“; stock code: 2257), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the Group has published a major advancement of its novel Oligonucleotide-Chemodrug Conjugate (ODC) agent. The ODC […]
Pr Newswire
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
13
Jun
Jun
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will present a company overview at the MST Access ‘Hidden Gems in Life […]
13
Jun
Jun
SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, announced today that the Board of […]
13
Jun
Jun
CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions. Prior to this announcement, the Company was scheduled to participate on June 13, 2024, at […]
Pr Newswire
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
13
Jun
Jun
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a scientific article in Nature Communications, unveiling a non-viral gene therapy approach for sickle cell disease. Sickle […]
13
Jun
Jun
Industry leader Barry Quart, Pharm.D. appointed as Chief Executive Officer succeeding Zheng Wei, Ph.D., who will remain on the Board of Directors and serve as an advisor to assist with the transition Experienced life science executive David Szekeres appointed as President Kleanthis G. Xanthopoulos, Ph.D. appointed as Chair of the Board of Directors SAN DIEGO, […]